Current indications for endoscopic submucosal dissection of early gastric cancer

Abstract

The development of endoscopic treatment technology has further promoted the minimally invasive treatment of early gastric cancer (EGC). Endoscopic treatment has achieved better therapeutic effects in terms of safety and prognosis and is the preferred treatment method for patients who meet the indications for endoscopic treatment. However, the consequent problem is that some patients receiving endoscopic treatment may undergo non-curative resection, and the principle of follow-up management for non-curative resection patients deserves further attention. In addition, there are still debates on how to improve the accuracy of clinical staging, select a reasonable treatment method for patients who meet the expanded indications for endoscopic treatment, manage patients with positive endoscopic surgical margins, conduct research on function-preserving surgery, and manage the treatment of EGC under the current situation in China. Consequently, we aim to review current indications for endoscopic submucosal dissection of EGC in order to better inform treatment options.

Comparing Different Anesthesia Methods on Anesthetic Effect and Postoperative Pain in Patients with Early Gastric Cancer during Endoscopic Submucosal Dissection

“…In recent years, with the popularization of gastroscopic examination and the increase of people's attention to their own health, more and more gastric cancer lesions can be diagnosed by endoscopy in the early stage [ 24 , 25 ]. Compared with traditional radical surgical resection, early gastric cancer located in the mucosa or submucosa can be treated with minimally invasive endoscopic submucosal dissection [ 26 ]. During the operation, scientific and effective anesthesia is the key to ensuring the smooth implementation of radical gastrectomy for gastric cancer and achieving ideal results [ 27 ].…”